Long-term Outcomes of Clopidogrel Monotherapy versus Prolonged Dual Antiplatelet Therapy beyond 12 Months after Percutaneous Coronary Intervention in High-risk Patients

BACKGROUND: There are no data on comparison between clopidogrel monotherapy and prolonged dual antiplatelet therapy (DAPT) in patients at high-risk undergoing percutaneous coronary intervention (PCI). METHODS: Of 2,082 consecutive patients undergoing PCI using second-generation drug-eluting stent (D...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Dong-Yeon, Cho, Sung Woo, Park, Kyu Tae, Ahn, Jong-Hwa, Park, Taek Kyu, Jang, Yong Ho, Choi, Ki Hong, Lee, Joo Myung, Yang, Jeong Hoon, Song, Young Bin, Choi, Jin-Ho, Choi, Seung-Hyuk, Gwon, Hyeon-Cheol, Lee, Sang Hoon, Hahn, Joo-Yong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Academy of Medical Sciences 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8076847/
https://www.ncbi.nlm.nih.gov/pubmed/33904262
http://dx.doi.org/10.3346/jkms.2021.36.e106

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8076847/
https://www.ncbi.nlm.nih.gov/pubmed/33904262
http://dx.doi.org/10.3346/jkms.2021.36.e106

Ejemplares similares